Response to purified chick embryo cell rabies vaccine administered intradermally for post-exposure prophylaxis

National Medical Journal of India

Volumn 10, Issue 3, 1997, Pages 115-116

  Madhusudana, S N ^a,b   Anand, N Prem ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^b M S RAMAIAH MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; RABIES VACCINE;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; ERYTHEMA; FEMALE; HUMAN; IMMUNIZATION; INJECTION SITE; INTRADERMAL DRUG ADMINISTRATION; MALE; PAIN; PRACTICE GUIDELINE; PRURITUS; RABIES; RABIES VIRUS; VACCINATION; VIRUS INFECTION; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; ALLIED HEALTH PERSONNEL; ANIMALS; ANTIBODIES, VIRAL; CHICK EMBRYO; FEMALE; HUMANS; INJECTIONS, INTRADERMAL; MALE; OCCUPATIONAL EXPOSURE; RABIES; RABIES VACCINES; TREATMENT OUTCOME;

EID: 0030835602     PISSN: 0970258X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Meslin FX. Report on the status of rabies in the world. Third international symposium on rabies in Asian countries. Wuhan, China:Marcel Merieux Foundation and the World Health Organization, 11-15 Sept 1996.
2. Dutta JK. Rabies prevention: Cost to an Indian labourer. JAMA 1996:276:32.
3. Nicholson KG, Prestag H, Cole PJ, Turner GS, Bauer SP. Multisite intradermal antirabies vaccination: Immune responses in man and protection of rabbits against death from street virus by post-exposure administration of human diploid-cell-strain rabies vaccine. Lancet 1981;2:915-18.
4. Warrell MJ, Nicholson KG, Warrell DA, Suntharasamai P, Chanthavanich P, Viravan CC, et al. Economic multiple site intradermal immunisation with human diploid-cell-strain vaccine is effective for post-exposure rabies prophylaxis. Lancet 1985;1:1059-62.
5. Madhusudana SN, Saha SM, Sood M, Saxena SN. Multisite intradermal vaccination with tissue culture vaccine as an economical prophylactic regimen against rabies. Indian J Med Res 1988;87:1-4.
6. Dutta JK, Warrell MJ, Dutta TK. Intradermal rabies immunization for pre- and post-exposure prophylaxis. Natl Med J India 1994;7:119-22.
7. Madhusudana SN. Cost-effective abbreviated regimens with cell culture rabies vaccines for post-exposure rabies prophylaxis. J Basic Appl Biomed 1996;4:5-9.
8. Chutivongse S, Wilde H, Supich C, Baer GM, Fishbein DB. Post-exposure prophylaxis for rabies with antiserum and intradermal vaccination. Lancet 1990;335: 896-8.
9. World Health Organization. WHO expert committee on rabies. Eighth report WHO Tech Rep Ser 1992;824:53-5.
10. Atanasiu P. Quantitative assay and potency test of antirabies serum and immunoglobulin. In: Kaplan MM, Koprowsky H (eds). Laboratory techniques in rabies. Geneva:World Health Organization, 1973:314-18.
11. Helmick CG, Tauxe RV, Veron AA. Is there a risk to contacts of patients with rabies? Rev Infect Dis 1987;9:511-18.
12. Fekadu M, Endeshaw T, Alemu W, Bogale Y, Teshager T, Olson JG. Possible human-to-human transmission of rabies in Ethiopia. Ethiop Med J 1996;1:23-6.
13. Phanuphak P, Khaoplod P, Benjavongkulchai M, Chutivongse S, Wilde H. What happens if intradermal injections of rabies vaccine are partially or entirely injected subcutaneously. Bull World Health Organ 1990;68:83-5.
14. Nicolas AJ, Patet J, Falquet JC, Branche R, Delaiti P, Montagnon B, et al. Production of inactivated rabies vaccine for human use on WI38 diploid cells: Results of potency tests. Stability of the vaccine in liquid and freeze-dried forms. Dev Biol Stand 1978;40:17-24.